Evidence map›Paper›PMID 29167954›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2018

No implant migration and good subjective outcome of a novel customized femoral resurfacing metal implant for focal chondral lesions.

Anders Stålman, Olof Sköldenberg, Nicolas Martinez-Carranza, David Roberts, Magnus Högström, Leif Ryd

Open access · hybridAbstract read
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. The cost-effectiveness of osteochondral allograft transplantation in the knee.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Patient-specific metal implants for focal chondral and osteochondral lesions in the knee; excellent clinical results at 2 years.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2021
    Observational
  10. Review
  11. Article
  12. Article
  13. Review
  14. What future in the treatment of osteochondral knee defects?Annals of translational medicine · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Anders StålmanStockholm Sports Trauma Research Center, Karolinska Institutet, Capio Artro Clinic, Sophiahemmet, Valhallavägen 91, 114 86, Stockholm, Sweden. anders.stalman@ki.se.ORCID http://orcid.org/0000-0002-6261-2024
Olof SköldenbergDepartment of Orthopaedics, Danderyd Hospital, Stockholm, Sweden.
Nicolas Martinez-CarranzaDepartment of Orthopaedics, Karolinska University Hospital, Stockholm, Sweden.
David RobertsDepartment of Orthopaedics, Skane University Hospital, Malmö, Sweden.
Magnus HögströmSports Medicine Umeå AB and Orthopedics, Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Leif RydLIME, Karolinska Institutet, Solna, Sweden.
Danderyds sjukhus · SEKarolinska Institutet · SEKarolinska University Hospital · SESkåne University Hospital · SESophiahemmet University College · SEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeManaging focal cartilage injuries in the middle-aged patient poses a challenge. Focal prosthetic inlay resurfacing has been proposed to be a bridge between biologics and conventional joint arthroplasty. Patient selection and accurate implant positioning is crucial to avoid increased contact pressure to the opposite cartilage surface. A customized femoral condyle implant for focal cartilage injuries was designed to precisely fit each patient's individual size and location of damage. The primary objective was to assess implant safety profile, surgical usability of the implant and instruments, and implant migration with radiostereometric analysis (RSA).

methodsTen patients 36-56 years with focal chondral defects, ICRS 3-4 of the femoral cartilage and failed earlier conservative or surgical interventions with VAS pain > 40. The patients were followed for 2 years with subjective outcome measures (VAS, EQ5D, KOOS) and RSA. The customized implant and guide instruments were manufactured by computer-aided design/computer-aided manufacturing (CAD/CAM) techniques using MRI data.

resultsVAS, EQ5D and KOOS showed improvements that reached significance for VAS (p ≤ 0.001), Tegner (p = 0.034) and the KOOS subscores ADL (p = 0.0048), sport and recreation (p = 0.034) and quality of life (p = 0.037). VAS and KOOS scores improved gradually at 3, 6 and 12 months. The improvements in EQ5D, KOOS pain and KOOS symptoms did not reach statistical significance. No infections, deep venous thrombosis or other complications occured in the postoperative period. No radiographic signs of damage to the opposing tibial cartilage was noted. The surgical usability of implants and instruments were good. RSA did not show any implant migration.

conclusionThis is the first clinical report of a new customized, focal knee resurfacing system. The short-term implant safety and patient-related outcome measures showed good-to-excellent results. LEVEL OF EVIDENCE: Prospective case series, Level 4.

Indexed as

Knee ProsthesisAdultArthroplasty, Replacement, KneeCartilage, ArticularCartilage DiseasesComputer-Aided DesignFemaleFemurHumansKnee JointMaleMetalsMiddle AgedPreoperative CareProspective StudiesProsthesis DesignMetalsFocal cartilage injuriesOsteochondral injuryProsthetic inlay resurfacing

Identifiers

PMID29167954
PMCPMC6061440
OpenAlexW2769942584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.